Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...

Preclinical testing by Hungarian researchers has shown that a newly developed compound can eliminate aggressive tumors in ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

A DNA aptamer nanostructure enables targeted doxorubicin delivery to AML cells, improving treatment efficacy and safety, ...

Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...

West Pharmaceutical Services (NYSE:WST) announced that it reached an agreement to sell on-body drug delivery technology to ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...

Lexeo says the collaboration will accelerate the development of an unnamed preclinical cardiac gene therapy target.